Clinical Trials Directory

Trials / Terminated

TerminatedNCT02058329

A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications

A Geriatric Home Visit Program to Reduce Post Hip Fracture Morbidity and Mortality

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The overall goal of the project is to reduce the incidence of post hip fracture morbidity and mortality by conducting geriatric fellow periodic home visits.The assessment will be multidisciplinary and will include assessments of functional status, depression, environmental risks and medical conditions. This group will be compared against a group followed by the usual standard of care post hip fracture.

Detailed description

All patients post hip fracture on the hospital's rehabilitation service that will be discharged to home will be enrolled after obtaining consent. Patients will be randomized into the intervention group and the usual standard of care group.We will be recruiting a total of 100 patients , with equal numbers for each group.All patients will undergo an initial assessment by a Geriatric fellow prior to discharge . The intervention group will be seen at the time of discharge in the hospital and at home at 1, 3, and 6 months post hip fracture. The control group will be seen at the time of discharge in the hospital and then again at 6 months for follow up. The two groups will then be compared for multiple known complications post hip fractures well as mortality.

Conditions

Interventions

TypeNameDescription
OTHERHome VisitA geriatric fellow will conduct a comprehensive in hospital post discharge assessment of hip fracture patients discharged to home in the intervention group.Follow up home visits will occur at 1,3 and 6 months post discharge.Any problems will be referred to the patient's primary care physician.

Timeline

Start date
2008-11-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2014-02-10
Last updated
2014-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02058329. Inclusion in this directory is not an endorsement.